Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...
Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...
A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...
ET Now on MSN
Novo Nordisk launches once-a-week insulin injection: Check Awiqli price, variants, dosage, etc
Danish pharmaceutical company Novo Nordisk has introduced a once-weekly basal insulin injection, Awiqli, which will allow ...
India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...
The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number ...
Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...
One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...
PLAINSBORO, N.J., March 26, 2026 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the ...
Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.
Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast ...
By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results